Constitutively active NF-κB promotes CSC survival, immune evasion, and therapy resistance [34].ROS-induced NF-κB activation enhances anti-apoptotic genes [35]Cross-talk with Notch and Wnt pathways sustains stemness and tumor progression [36]. This evidence concerns the gene NFKB1 and neoplasm.